Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Sleep apnea is a common type of sleep disorder which happens when an individual is having trouble inbreathing during sleep were breathing repeatedly stops and starts. Sleep apnea devices are primarily provided as primarily provided as diagnostic and therapeutic devices in order to treat obstructive sleep apnea syndrome. Continuos positive airway pressure is highly recommended devices for the management of obstructive sleep apnea.
The North America obstructive sleep apnea market is witnessing lucrative growth during the forecast period of 2022-2028. The growing prevalence of chronic diseases such as cancer, arthritis, metabolic disorder, orthopaedics, respiratory and cardiovascular diseases is propelling growth of North America obstructive sleep apnea market. The rising geriatric population is also boosting growth of North America obstructive sleep apnea market. However, dearth of skilled professionals is hindering the growth of North America obstructive sleep apnea market.
The exclusive COVID-19 impact analysis report by axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the obstructive sleep apnea market. In addition, complete analysis of changes on the obstructive sleep apnea expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North America economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The market witnessed the growth during owing to sudden outbreak of the COVID-19 pandemic. In first quarter of 2020, companies faced some operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and adverse impact of the virus on sleep apnea patients leads to rise in the demand and production of sleep apnea devices.
The North America obstructive sleep apnea market is bifurcated into the type, end user and country.
By type, the North America obstructive sleep apnea market is segmented into airway clearance systems, adaptive servo-ventilation, positive airway pressure device, oral appliance and oxygen devices. The oral appliances are also contributing to the growth of North America obstructive sleep apnea market. The rising use of oral appliances is propelling growth of North America obstructive sleep apnea market. The rising awareness regarding use of oral appliances for management of sleep apnea is also boosting growth of North America obstructive sleep apnea market.
Various end users such as home care settings and hospitals and sleep laboratories are comprised in the North America obstructive sleep apnea market. The hospital and sleep laboratories are also contributing to the growth of North America obstructive sleep apnea market. The growing research and development is sleep diagnostic is boosting growth of North America obstructive sleep apnea market. The growing prevalence of chronic diseases due to sleep disorders is also propelling growth of North America obstructive sleep apnea market.
The North America obstructive sleep apnea market is studied for key countries such as United States, Canada and Mexico. The United States is anticipated to dominate the market in 2020. The rising patient footfall is propelling growth of North America obstructive sleep apnea market. The growing geriatric population is also propelling growth of North America obstructive sleep apnea market. The increasing research and development activities is healthcare is also boosting growth of North America obstructive sleep apnea market.
The major key players of the markets are Becton Dickinson (CareFusion Corporation), BMC Medical Co. Ltd, Braebon Medical Corporation, Cadwell Laboratories Inc., Compumedics Limited, Curative Medical Inc, Fisher & Paykel Healthcare, GE Healthcare, ImThera, Invacare Corporation, Koninklijke Philips N.V., LivaNova, Nidek Medical India, Inspire Medical System, Somnomed, Oventus Medical and Drive Devilbiss Healthcare among others.
February 2021: The Cadwell acquired Sleepmate sleep diagnostic sensors from Ambu A/S. The Sleepmate products have been providing high quality and reliable sleep diagnostic sensor solutions for more than 30 years. Cadwell is now honoured to comprise Sleepmate portfolio as an integral part of its comprehensive sleep diagnostic solutions for both in-lab and at home testing.
August 2021: ResMed had launched their new positive airway pressure device in the US to help hundreds of millions of people with sleep apnea.
September 2020: ResMed launched first CPAP Nasal Mask with memory foam. The company recently launched their first continuos positive airway pressure (CPAP) nasal mask with a memory foam cushion, the AirTouch N20. As per the company it is the softest nasal mask till date.
October 2019: ResMed Launched AirFit N30 mask, a tube-down nasal cradle CPAP mask with a front tub which is a new option for sleep apnea treatment. ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, a nasal cradle cushion which sits under nasal bridge, eliminating soreness in those areas. The masks curved cushion is designed for supplying a secured seal regardless of how the wearer sleeps or moves.
The report analyses obstructive sleep apnea (OSA) market based on type, end user and country. By type, the market is segmented into the airway clearance system, adaptive servo-ventilation, positive airway pressure device, oral appliances and oxygen devices. Based on end user, the market is bifurcated into homecare settings and hospital and sleep laboratories. The report also analyses the impact of COVID-19 on the market and it analysed that The market witnessed the growth during owing to sudden outbreak of the COVID-19 pandemic. In first quarter of 2020, companies faced some operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and adverse impact of the virus on sleep apnea patients leads to rise in the demand and production of sleep apnea devices. The report also comprised of major key players operating in the market.
Why to buy this report:
